Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Angelico

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Transplantation Proceedings|March 20, 1999
Hepatitis C reinfection after liver transplantation in relation to virus genotypeG Tisone, L Baiocchi, G Orlando, et al.
Transplantation Proceedings|May 28, 2005
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation settingF Muzi, G Orlando, B Ielpo, et al.
Digestive Diseases and Sciences|April 29, 1998
Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation?N Figura, F Cetta, M Angelico, et al.
The Journal of Infection|January 19, 2002
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipientsM Andreoni, D Goletti, P Pezzotti, et al.
Journal of Hepatology|February 1, 1997
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infectionsM Angelico, E Renganathan, C Gandin, et al.
Clinical and Experimental Immunology|April 12, 2001
Lack of evidence for the Th2 predominance in patients with chronic hepatitis CA Bergamini, F Bolacchi, G Cerasari, et al.
Clinical and Experimental Immunology|April 12, 2001
Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis CA Bergamini, F Bolacchi, M Cepparulo, et al.
Antiviral Research|September 17, 2011
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugsR Salpini, V Svicher, V Cento, et al.
Journal of Medical Virology|April 17, 2013
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceR Salpini, C Alteri, V Cento, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 12, 2009
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumoniaG Orlando, L Tariciotti, T M Manzia, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Transplantation Proceedings|March 20, 1999
Hepatitis C reinfection after liver transplantation in relation to virus genotypeG Tisone, L Baiocchi, G Orlando, et al.
Transplantation Proceedings|May 28, 2005
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation settingF Muzi, G Orlando, B Ielpo, et al.
Digestive Diseases and Sciences|April 29, 1998
Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation?N Figura, F Cetta, M Angelico, et al.
The Journal of Infection|January 19, 2002
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipientsM Andreoni, D Goletti, P Pezzotti, et al.
Journal of Hepatology|February 1, 1997
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infectionsM Angelico, E Renganathan, C Gandin, et al.
Clinical and Experimental Immunology|April 12, 2001
Lack of evidence for the Th2 predominance in patients with chronic hepatitis CA Bergamini, F Bolacchi, G Cerasari, et al.
Clinical and Experimental Immunology|April 12, 2001
Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis CA Bergamini, F Bolacchi, M Cepparulo, et al.
Antiviral Research|September 17, 2011
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugsR Salpini, V Svicher, V Cento, et al.
Journal of Medical Virology|April 17, 2013
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceR Salpini, C Alteri, V Cento, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 12, 2009
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumoniaG Orlando, L Tariciotti, T M Manzia, et al.
Pageof 13